腫瘍治療機器市場- 世界の産業規模、シェア、動向、機会、予測、種類別、用途別、地域別、競争別、2020-2030F

世界の腫瘍治療機器市場は、2024年に141億米ドルと評価され、2030年までのCAGRは6.50%で、予測期間中に目覚ましい成長を示すと予測されています。

腫瘍治療とは、体内の腫瘍や異常増殖の診断、管理、除去を目的とした医療介入や治療を指します。腫瘍には良性（非がん性）と悪性（がん性）があります。治療法の選択は、腫瘍の種類、部位、大きさ、病期、その他の特徴、および患者さんの全身状態や嗜好によって異なります。腫瘍の外科的切除は一般的な治療法であり、特に限局性でアクセスしやすい腫瘍に適しています。場合によっては、外傷や回復時間を減らすために、腹腔鏡手術やロボット支援手術などの低侵襲手術が用いられます。外科医は、完全な切除を確実にするために、健康な組織のマージンと共に腫瘍全体を切除することを目指しています。腫瘍治療は個別性が高く、治療の選択は腫瘍の種類や病期、患者さんの全身状態、治療目標（治癒、緩和、症状管理）などの要因によって異なります。治療計画は多くの場合、腫瘍内科医、外科医、放射線腫瘍医、その他のヘルスケア専門家が関与する集学的アプローチによって策定されます。

市場促進要因

技術の進歩

主な市場課題

治療コスト

主な市場動向

低侵襲手術

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の腫瘍治療機器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 種類別（手術機器、放射線治療機器、化学治療機器）
  • 用途別（肺がん、直腸がん、乳がん、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 アジア太平洋地域の腫瘍治療機器市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の腫瘍治療機器市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の腫瘍治療機器市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の腫瘍治療機器市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの腫瘍治療機器市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の腫瘍治療機器市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• Boston Scientific Corp
• Medtronic Plc
• Johnson & Johnson
• Merit Medical System Inc.
• Varian Medical System Inc.
• AngioDynamics Inc.
• HealthTronics Inc.
• SonaCare Medical LLC
• Misonix Inc.
• CAScination AG

第17章 戦略的提言

第18章 調査会社について・免責事項

Global Tumor Treatment Equipment Market was valued at USD 14.10 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 6.50% through 2030. Tumor treatment refers to the medical interventions and therapies aimed at diagnosing, managing, and eliminating tumors or abnormal growths in the body. Tumors can be benign (non-cancerous) or malignant (cancerous). The choice of treatment depends on the type, location, size, stage, and other characteristics of the tumor, as well as the patient's overall health and preferences. Surgical removal of the tumor is a common treatment option, particularly for localized and easily accessible tumors. In some cases, minimally invasive surgery, such as laparoscopy or robotic-assisted surgery, is used to reduce trauma and recovery time. Surgeons aim to remove the entire tumor along with a margin of healthy tissue to ensure complete removal. Tumor treatment is highly individualized, and the choice of therapy depends on factors like the type and stage of the tumor, the patient's overall health, and the treatment goals (curative, palliative, or symptom management). Treatment plans are often developed through a multidisciplinary approach involving oncologists, surgeons, radiation oncologists, and other healthcare professionals.

Key Market Drivers

Technological Advancements

Image-Guided Radiation Therapy (IGRT) allows for real-time imaging of the tumor and surrounding tissues during radiation therapy. For instance, in December 2024, AngioDynamics, Inc. announced that it had secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NanoKnife System, designed for prostate tissue ablation. This regulatory approval marks a significant milestone, enabling the company to offer a minimally invasive treatment option for prostate conditions, further expanding its innovative medical device portfolio.

Also, in March 2024, Medtronic plc, a global leader in healthcare technology, announced it had received U.S. FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system. This advanced system is designed to treat painful bone metastases and benign bone tumors like osteoid osteoma, enhancing treatment options for patients. Advanced imaging techniques, such as cone-beam CT and MRI, enable precise tumor targeting, minimizing damage to healthy tissue. Intensity-Modulated Radiation Therapy (IMRT) delivers radiation with varying intensity levels, allowing for precise dose modulation. It can conform radiation beams to the shape of the tumor, sparing nearby critical organs. Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) use highly focused radiation beams to treat small tumors or lesions with extreme precision. They are often used for brain tumors, lung tumors, and metastatic lesions in the body. Proton therapy uses protons instead of traditional X-rays for radiation treatment. Protons have precise energy deposition, sparing healthy tissue and reducing the risk of side effects. Cryoablation uses extreme cold to freeze and destroy tumor tissue. It is minimally invasive and can be used for various cancer types, including prostate and kidney cancer. Robotic-assisted surgery provides surgeons with enhanced precision and dexterity during procedures. It is commonly used in procedures like robotic-assisted prostatectomy. Targeted therapies are drugs that specifically target cancer cells or specific molecular pathways. Advancements in understanding cancer genetics have led to the development of more targeted and effective treatments.

Key Market Challenges

Cost of Treatment

Tumor treatment equipment, such as advanced radiation therapy machines, surgical robots, and imaging devices, can be expensive to acquire and maintain. These costs are often passed on to healthcare facilities and patients. Many cancer treatments involve the use of expensive pharmaceuticals, including chemotherapy drugs and targeted therapies. The cost of these drugs can be a significant portion of the overall treatment expenses. As tumor treatment equipment becomes more technologically advanced, it often comes with higher price tags. These technologies are essential for delivering effective and precise treatments. Cancer treatment often involves multiple modalities over an extended period, including surgery, radiation therapy, chemotherapy, and immunotherapy. The cumulative cost of these treatments can be substantial. Managing the side effects of cancer treatment, such as pain management, supportive care, and addressing treatment-related complications, adds to the overall cost. While personalized medicine can lead to more effective treatments, it can also be expensive due to the need for genetic testing, biomarker analysis, and customized drug regimens. The availability and adequacy of health insurance coverage can impact the financial burden on patients. Insufficient coverage may result in high out-of-pocket costs. Even with insurance, patients often face copayments, deductibles, and other out-of-pocket expenses, which can be financially challenging, especially for long-term treatments. In some regions, access to advanced tumor treatment equipment and therapies may be limited, either due to the lack of healthcare infrastructure or cost constraints. This can result in disparities in access to care.

Key Market Trends

Minimally Invasive Surgery

MIS techniques minimize damage to surrounding healthy tissues, resulting in less surgical trauma and a faster recovery for patients. Patients who undergo minimally invasive surgery often experience shorter hospital stays compared to traditional open surgery, reducing healthcare costs. Smaller incisions and reduced tissue exposure can lower the risk of postoperative infections. Advanced equipment, such as robotic surgical systems, provides surgeons with enhanced precision and dexterity during procedures, allowing for more precise tumor removal. Smaller incisions result in less scarring, which can lead to improved cosmetic outcomes and increased patient satisfaction. Robotic-assisted surgery is a subcategory of MIS that has seen significant growth. Surgical robots offer three-dimensional visualization and greater maneuverability during procedures. MIS is being used for the treatment of various tumors, including those in the prostate, kidney, liver, lung, and colon. The versatility of minimally invasive techniques is driving adoption. Advanced imaging technologies, such as laparoscopic and endoscopic ultrasound, aid in tumor localization and surgical planning during minimally invasive procedures. Minimally invasive surgery is associated with less postoperative pain and discomfort for patients, improving their overall experience. Patients undergoing MIS typically experience faster recovery times, allowing them to return to their normal activities sooner. Many patients prefer minimally invasive approaches when suitable because of the perceived benefits in terms of recovery and reduced scarring. Equipment used in minimally invasive surgery is continually evolving, incorporating features like improved visualization, instrument articulation, and haptic feedback.

Key Market Players

• Boston Scientific Corp
• Medtronic plc.
• Johnson & Johnson
• Merit Medical Inc.
• Varian Medical Inc.
• AngioDynamics Inc.
• HealthTronics Inc.
• SonaCare Medical LLC
• Misonix Inc.
• CAScination AG

Report Scope:

In this report, the Global Tumor Treatment Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tumor Treatment Equipment Market, By Type:

• Surgical Equipment
• Radiotherapy Equipment
• Chemotherapy Equipment

Tumor Treatment Equipment Market, By Application:

• Lung Cancer
• Rectal Cancer
• Breast Cancer
• Other

Tumor Treatment Equipment Market, By region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tumor Treatment Equipment Market.

Available Customizations:

Global Tumor Treatment Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tumor Treatment Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Surgical Equipment, Radiotherapy Equipment, Chemotherapy Equipment)
  • 5.2.2. By Application (Lung Cancer, Rectal Cancer, Breast Cancer, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Tumor Treatment Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Tumor Treatment Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. India Tumor Treatment Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Australia Tumor Treatment Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
  • 6.3.4. Japan Tumor Treatment Equipment Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Application
  • 6.3.5. South Korea Tumor Treatment Equipment Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Application

7. Europe Tumor Treatment Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Tumor Treatment Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Tumor Treatment Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. Spain Tumor Treatment Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Tumor Treatment Equipment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. United Kingdom Tumor Treatment Equipment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. North America Tumor Treatment Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Tumor Treatment Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. Mexico Tumor Treatment Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. Canada Tumor Treatment Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application

9. South America Tumor Treatment Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Tumor Treatment Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Tumor Treatment Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Tumor Treatment Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Tumor Treatment Equipment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Tumor Treatment Equipment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Tumor Treatment Equipment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Tumor Treatment Equipment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Tumor Treatment Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Boston Scientific Corp
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. Medtronic Plc
  • 16.2.1. Business Overview
  • 16.2.2. Company Snapshot
  • 16.2.3. Products & Services
  • 16.2.4. Financials (In case of listed companies)
  • 16.2.5. Recent Developments
  • 16.2.6. SWOT Analysis
• 16.3. Johnson & Johnson
  • 16.3.1. Business Overview
  • 16.3.2. Company Snapshot
  • 16.3.3. Products & Services
  • 16.3.4. Financials (In case of listed companies)
  • 16.3.5. Recent Developments
  • 16.3.6. SWOT Analysis
• 16.4. Merit Medical System Inc.
  • 16.4.1. Business Overview
  • 16.4.2. Company Snapshot
  • 16.4.3. Products & Services
  • 16.4.4. Financials (In case of listed companies)
  • 16.4.5. Recent Developments
  • 16.4.6. SWOT Analysis
• 16.5. Varian Medical System Inc.
  • 16.5.1. Business Overview
  • 16.5.2. Company Snapshot
  • 16.5.3. Products & Services
  • 16.5.4. Financials (In case of listed companies)
  • 16.5.5. Recent Developments
  • 16.5.6. SWOT Analysis
• 16.6. AngioDynamics Inc.
  • 16.6.1. Business Overview
  • 16.6.2. Company Snapshot
  • 16.6.3. Products & Services
  • 16.6.4. Financials (In case of listed companies)
  • 16.6.5. Recent Developments
  • 16.6.6. SWOT Analysis
• 16.7. HealthTronics Inc.
  • 16.7.1. Business Overview
  • 16.7.2. Company Snapshot
  • 16.7.3. Products & Services
  • 16.7.4. Financials (In case of listed companies)
  • 16.7.5. Recent Developments
  • 16.7.6. SWOT Analysis
• 16.8. SonaCare Medical LLC
  • 16.8.1. Business Overview
  • 16.8.2. Company Snapshot
  • 16.8.3. Products & Services
  • 16.8.4. Financials (In case of listed companies)
  • 16.8.5. Recent Developments
  • 16.8.6. SWOT Analysis
• 16.9. Misonix Inc.
  • 16.9.1. Business Overview
  • 16.9.2. Company Snapshot
  • 16.9.3. Products & Services
  • 16.9.4. Financials (In case of listed companies)
  • 16.9.5. Recent Developments
  • 16.9.6. SWOT Analysis
• 16.10.CAScination AG
  • 16.10.1. Business Overview
  • 16.10.2. Company Snapshot
  • 16.10.3. Products & Services
  • 16.10.4. Financials (In case of listed companies)
  • 16.10.5. Recent Developments
  • 16.10.6. SWOT Analysis

17. Strategic Recommendations

18. About Us & Disclaimer